VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here: IndiaNotes >> Market Insights - 16 November 2016 >> Why is it a good time to invest in Sun Pharma? - IndiaNotes.com Market Insights Newsletter
16 | November | 2016 To view mail in browser, please click here Follow us on LinkedIn
IndiaNotes.com - Market Insights...take informed decisions
Research your Stock   |    Technical Calls   |    Live Market Action   |    Archives   |    Join Xchange

Welcome to Market Insights,

In this edition, we have Dynamic Levels discussing whether is it a good time to invest in Sun Pharma and why should investors stick to large-caps in the current scenario. In fundamental recommendations, we have CD Equisearch reaffirming their 'buy' rating on Inox Wind but downgrading the target, HDFC Securities recommending to buy Goodyear India at CMP and to add on declines, and SMC recommending NTPC and Gujarat State Petronet for a tenure of 8-10 months.

 

If you like us, please rate us on Facebook.


Pick of the week: Buy Goodyear at CMP and add on declines

According to HDFC Securities, Goodyear India Ltd being an MNC and a dominant player in tractor tyres segment is well placed to benefit out of increasing demand for tractors (and in replacement market) due to healthy monsoon in FY17. Investors can buy the stock at CMP and add on dips to Rs. 688-700 band.

Click here to read the elaborate report by HDFC Securities


Fundamental picks: These stocks have an upside of 20% each
SMC are recommending NTPC and Gujarat State Petronet on fundamental grounds for a tenure of 8-10 months. They find NTPC as the most preferred power company. They also see Gujarat State Petronet having developed requisite expertise and confidence with proven project management competencies. Thus, they are also sharing with us the targets for both the scrips, which imply an upside potential of 20% each.

Why is it a good time to invest in Sun Pharma?
According to Dynamic Levels, the performance of Sun Pharmaceutical Industries on the bourses in the recent months has been more miserable than its ground performance. While the Street has factored in most of the negatives or risks that have affected or could impact the company's business, there also exist many causes which could provide upside to the stock; and these should aid the company to perform strongly in spite of the challenges of pricing pressure and regulatory risks.



Inox Wind: CD Equisearch reaffirm 'buy' rating but revise target downward
According to CD Equisearch, the impetus provided by the government to this industry provides some consolation. With the management's plans to overcome operational difficulties by next couple of quarters and exploit the scope of this industry, we re-affirm our previous rating of "buy" with a target revised downward from the previous of Rs. 322 based on 13x FY18e earnings, over a period of 9-12 months.

Small-caps Fall like House Of Cards, Stick to Large-caps
According to Dynamic Levels, some of the investor's favorite small-cap stocks are falling like ninepins. At the start of the month, the BSE Small-cap index was just 7 per cent away from striking an all-time high after eight years. But the recent slither in the market, more so in small-cap stocks, showed the limitations in the space.

Featured Equity Call for today by Dharmesh Bhatt
AXIS Bank: Selling on higher levels will be seen. . . .    read more  
Get day to day calls and stock tips with our Technical Newsletter section - Follow this page on LinkedIn here

If you would like to contribute your content, get in touch with us at write@indianotes.com
Do write in at
indianotes.editor@gmail.com and give us your feedback!

 
Advertise with us  |   Write for us   |   Blog on Xchange  |   Archives  |   Feedback
 
Privacy Policy